Small cell lung cancer (SCLC) is one of the two major types of lung cancer. It is named because the cells appear small and round under the microscope. Facts You Should Know About Small-Cell Lung Cancer When cells of the lung start to undergo a degenerative transformation in appearance and ...
Objective: Small cell lung cancer (SCLC) constitutes about 15-25 % of lung cancers with high mortality rate. Herein we observed the effect of parameters at the time of diagnosis to survival of cases with SCLC. Methods: We evaluated 65 patients who were followed up in our oncology departme...
Regional (cancer has spread outside the lung or to lymph nodes): 33% Distant (cancer has moved farther, such as to the brain, the other lung, and bones): 6% All stages: 23% Relative survival rates for small-cell lung cancer (SCLC): This is a rare but more aggressive lung cancer. ...
Metastasis to the bones is most common with small cell cancers but also occurs with other lung cancer types. Lung cancer that has metastasized to the bone causes bone pain, usually in the backbone (vertebrae), the large bones of the thigh (the femurs), the pelvic bones, and the ribs. Lu...
. Although small cell lung cancer is very sensitive to radiotherapy and chemotherapy, it is highly prone to recurrence[84,85]. Currently, treatments are limited for these patients, resulting in a poor prognosis. Small cell lung cancer is a very lethal cancer with a 5-year survival rate of ...
Small cell lung cancer (SCLC) represents up to 25 percent of lung cancer cell deaths and is associated with early metastasis and poor patient survival. Thus, SCLC is in need of better therapeutics and more efficient targeted treatments.
Small-cell lung cancer (SCLC) represents about 15% of all lung cancers and is marked by an exceptionally high proliferative rate, strong predilection for early metastasis and poor prognosis. SCLC is strongly associated with exposure to tobacco carcinogens. Most patients have metastatic disease at dia...
There are two main types of lung cancer: non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). The majority of lung cancer patients have NSCLC, which usually grows and spreads more slowly and has a better 5-year overall survival rate than SCLC (NCI 2013a; NCI 2013c; ...
Small-cell lung cancer (SCLC), which is characterized by rapid doubling time and extensive early metastasis, has a 5-year survival rate of less than 7% due to the lack of methods for its early detection [2]. Most patients with SCLC only survive 1 year or less after diagnosis [3]. ...
Consolidation durvalumab improved survival across subgroups of patients with limited-stage small cell lung cancer based on factors associated with prior prophylactic cranial irradiation and concurrent chemoradiotherapy use. Among patients with prior PCI in the durvalumab and placebo arms, the median ...